nodes	percent_of_prediction	percent_of_DWPC	metapath
Escitalopram—CYP2C19—coronary artery disease	0.215	1	CbGaD
Escitalopram—CYP2C19—Gemfibrozil—coronary artery disease	0.0303	0.0726	CbGbCtD
Escitalopram—CYP2C19—Clopidogrel—coronary artery disease	0.0263	0.0629	CbGbCtD
Escitalopram—CYP2C19—Telmisartan—coronary artery disease	0.023	0.055	CbGbCtD
Escitalopram—CYP3A4—Ticagrelor—coronary artery disease	0.0206	0.0492	CbGbCtD
Escitalopram—CYP2C19—Timolol—coronary artery disease	0.0185	0.0443	CbGbCtD
Escitalopram—CYP3A4—Fenofibrate—coronary artery disease	0.0183	0.0439	CbGbCtD
Escitalopram—CYP2C19—Rosuvastatin—coronary artery disease	0.017	0.0405	CbGbCtD
Escitalopram—CYP2C19—Acetylsalicylic acid—coronary artery disease	0.0165	0.0395	CbGbCtD
Escitalopram—CYP2C19—Simvastatin—coronary artery disease	0.0158	0.0377	CbGbCtD
Escitalopram—CYP2C19—Lovastatin—coronary artery disease	0.0154	0.0369	CbGbCtD
Escitalopram—CYP2D6—Niacin—coronary artery disease	0.0152	0.0363	CbGbCtD
Escitalopram—CYP3A4—Gemfibrozil—coronary artery disease	0.0147	0.0351	CbGbCtD
Escitalopram—CYP2D6—Timolol—coronary artery disease	0.0141	0.0337	CbGbCtD
Escitalopram—CYP2C19—Atorvastatin—coronary artery disease	0.014	0.0336	CbGbCtD
Escitalopram—CYP2C19—Losartan—coronary artery disease	0.0128	0.0307	CbGbCtD
Escitalopram—CYP3A4—Clopidogrel—coronary artery disease	0.0127	0.0304	CbGbCtD
Escitalopram—CYP2D6—Captopril—coronary artery disease	0.0124	0.0297	CbGbCtD
Escitalopram—CYP2D6—Simvastatin—coronary artery disease	0.012	0.0287	CbGbCtD
Escitalopram—CYP3A4—Eplerenone—coronary artery disease	0.0118	0.0283	CbGbCtD
Escitalopram—CYP2D6—Pravastatin—coronary artery disease	0.0117	0.028	CbGbCtD
Escitalopram—CYP2D6—Lovastatin—coronary artery disease	0.0117	0.028	CbGbCtD
Escitalopram—CYP2D6—Atorvastatin—coronary artery disease	0.0107	0.0255	CbGbCtD
Escitalopram—CYP3A4—Enalapril—coronary artery disease	0.0105	0.0252	CbGbCtD
Escitalopram—CYP3A4—Ezetimibe—coronary artery disease	0.00819	0.0196	CbGbCtD
Escitalopram—CYP3A4—Rosuvastatin—coronary artery disease	0.00819	0.0196	CbGbCtD
Escitalopram—CYP3A4—Simvastatin—coronary artery disease	0.00762	0.0182	CbGbCtD
Escitalopram—CYP3A4—Pravastatin—coronary artery disease	0.00746	0.0178	CbGbCtD
Escitalopram—CYP3A4—Lovastatin—coronary artery disease	0.00746	0.0178	CbGbCtD
Escitalopram—CYP3A4—Atorvastatin—coronary artery disease	0.00679	0.0162	CbGbCtD
Escitalopram—CYP3A4—Losartan—coronary artery disease	0.00621	0.0149	CbGbCtD
Escitalopram—Citalopram—CYP2C19—coronary artery disease	0.00131	1	CrCbGaD
Escitalopram—Malaise—Lisinopril—coronary artery disease	2.94e-05	0.000109	CcSEcCtD
Escitalopram—Oedema—Ramipril—coronary artery disease	2.93e-05	0.000109	CcSEcCtD
Escitalopram—Anaphylactic shock—Ramipril—coronary artery disease	2.93e-05	0.000109	CcSEcCtD
Escitalopram—Vertigo—Lisinopril—coronary artery disease	2.92e-05	0.000109	CcSEcCtD
Escitalopram—Dry mouth—Timolol—coronary artery disease	2.92e-05	0.000109	CcSEcCtD
Escitalopram—Pain—Losartan—coronary artery disease	2.92e-05	0.000109	CcSEcCtD
Escitalopram—Constipation—Losartan—coronary artery disease	2.92e-05	0.000109	CcSEcCtD
Escitalopram—Syncope—Lisinopril—coronary artery disease	2.92e-05	0.000109	CcSEcCtD
Escitalopram—Vomiting—Eplerenone—coronary artery disease	2.92e-05	0.000109	CcSEcCtD
Escitalopram—Feeling abnormal—Furosemide—coronary artery disease	2.92e-05	0.000109	CcSEcCtD
Escitalopram—Leukopenia—Lisinopril—coronary artery disease	2.91e-05	0.000108	CcSEcCtD
Escitalopram—Nausea—Fenofibrate—coronary artery disease	2.91e-05	0.000108	CcSEcCtD
Escitalopram—Pruritus—Niacin—coronary artery disease	2.91e-05	0.000108	CcSEcCtD
Escitalopram—Asthenia—Pravastatin—coronary artery disease	2.9e-05	0.000108	CcSEcCtD
Escitalopram—Gastrointestinal pain—Furosemide—coronary artery disease	2.89e-05	0.000108	CcSEcCtD
Escitalopram—Rash—Eplerenone—coronary artery disease	2.89e-05	0.000108	CcSEcCtD
Escitalopram—Urticaria—Perindopril—coronary artery disease	2.89e-05	0.000108	CcSEcCtD
Escitalopram—Hypersensitivity—Trandolapril—coronary artery disease	2.89e-05	0.000108	CcSEcCtD
Escitalopram—Dermatitis—Eplerenone—coronary artery disease	2.89e-05	0.000108	CcSEcCtD
Escitalopram—Diarrhoea—Valsartan—coronary artery disease	2.89e-05	0.000107	CcSEcCtD
Escitalopram—Confusional state—Timolol—coronary artery disease	2.89e-05	0.000107	CcSEcCtD
Escitalopram—Shock—Ramipril—coronary artery disease	2.88e-05	0.000107	CcSEcCtD
Escitalopram—Hypersensitivity—Enalapril—coronary artery disease	2.88e-05	0.000107	CcSEcCtD
Escitalopram—Abdominal pain—Perindopril—coronary artery disease	2.88e-05	0.000107	CcSEcCtD
Escitalopram—Body temperature increased—Perindopril—coronary artery disease	2.88e-05	0.000107	CcSEcCtD
Escitalopram—Palpitations—Lisinopril—coronary artery disease	2.88e-05	0.000107	CcSEcCtD
Escitalopram—Diarrhoea—Olmesartan—coronary artery disease	2.88e-05	0.000107	CcSEcCtD
Escitalopram—Headache—Eplerenone—coronary artery disease	2.88e-05	0.000107	CcSEcCtD
Escitalopram—Nervous system disorder—Ramipril—coronary artery disease	2.87e-05	0.000107	CcSEcCtD
Escitalopram—Thrombocytopenia—Ramipril—coronary artery disease	2.87e-05	0.000107	CcSEcCtD
Escitalopram—Anaphylactic shock—Timolol—coronary artery disease	2.86e-05	0.000107	CcSEcCtD
Escitalopram—Oedema—Timolol—coronary artery disease	2.86e-05	0.000107	CcSEcCtD
Escitalopram—Pruritus—Pravastatin—coronary artery disease	2.86e-05	0.000106	CcSEcCtD
Escitalopram—Loss of consciousness—Lisinopril—coronary artery disease	2.86e-05	0.000106	CcSEcCtD
Escitalopram—Nausea—Clopidogrel—coronary artery disease	2.86e-05	0.000106	CcSEcCtD
Escitalopram—Tachycardia—Ramipril—coronary artery disease	2.86e-05	0.000106	CcSEcCtD
Escitalopram—Skin disorder—Ramipril—coronary artery disease	2.84e-05	0.000106	CcSEcCtD
Escitalopram—Infection—Timolol—coronary artery disease	2.84e-05	0.000106	CcSEcCtD
Escitalopram—Vomiting—Simvastatin—coronary artery disease	2.84e-05	0.000106	CcSEcCtD
Escitalopram—Hypersensitivity—Telmisartan—coronary artery disease	2.84e-05	0.000106	CcSEcCtD
Escitalopram—Cough—Lisinopril—coronary artery disease	2.84e-05	0.000106	CcSEcCtD
Escitalopram—Nausea—Lovastatin—coronary artery disease	2.84e-05	0.000106	CcSEcCtD
Escitalopram—Hyperhidrosis—Ramipril—coronary artery disease	2.83e-05	0.000105	CcSEcCtD
Escitalopram—Rash—Simvastatin—coronary artery disease	2.82e-05	0.000105	CcSEcCtD
Escitalopram—Dermatitis—Simvastatin—coronary artery disease	2.82e-05	0.000105	CcSEcCtD
Escitalopram—Asthenia—Trandolapril—coronary artery disease	2.82e-05	0.000105	CcSEcCtD
Escitalopram—Shock—Timolol—coronary artery disease	2.82e-05	0.000105	CcSEcCtD
Escitalopram—Feeling abnormal—Losartan—coronary artery disease	2.81e-05	0.000105	CcSEcCtD
Escitalopram—Urticaria—Furosemide—coronary artery disease	2.81e-05	0.000105	CcSEcCtD
Escitalopram—Diarrhoea—Niacin—coronary artery disease	2.81e-05	0.000105	CcSEcCtD
Escitalopram—Nervous system disorder—Timolol—coronary artery disease	2.81e-05	0.000104	CcSEcCtD
Escitalopram—Asthenia—Enalapril—coronary artery disease	2.81e-05	0.000104	CcSEcCtD
Escitalopram—Headache—Simvastatin—coronary artery disease	2.8e-05	0.000104	CcSEcCtD
Escitalopram—Abdominal pain—Furosemide—coronary artery disease	2.8e-05	0.000104	CcSEcCtD
Escitalopram—Body temperature increased—Furosemide—coronary artery disease	2.8e-05	0.000104	CcSEcCtD
Escitalopram—Gastrointestinal pain—Losartan—coronary artery disease	2.79e-05	0.000104	CcSEcCtD
Escitalopram—Dizziness—Valsartan—coronary artery disease	2.79e-05	0.000104	CcSEcCtD
Escitalopram—Anorexia—Ramipril—coronary artery disease	2.79e-05	0.000104	CcSEcCtD
Escitalopram—Nausea—Ezetimibe—coronary artery disease	2.79e-05	0.000104	CcSEcCtD
Escitalopram—Skin disorder—Timolol—coronary artery disease	2.78e-05	0.000103	CcSEcCtD
Escitalopram—Dizziness—Olmesartan—coronary artery disease	2.78e-05	0.000103	CcSEcCtD
Escitalopram—Pruritus—Trandolapril—coronary artery disease	2.78e-05	0.000103	CcSEcCtD
Escitalopram—Arthralgia—Lisinopril—coronary artery disease	2.77e-05	0.000103	CcSEcCtD
Escitalopram—Chest pain—Lisinopril—coronary artery disease	2.77e-05	0.000103	CcSEcCtD
Escitalopram—Myalgia—Lisinopril—coronary artery disease	2.77e-05	0.000103	CcSEcCtD
Escitalopram—Hyperhidrosis—Timolol—coronary artery disease	2.77e-05	0.000103	CcSEcCtD
Escitalopram—Asthenia—Telmisartan—coronary artery disease	2.77e-05	0.000103	CcSEcCtD
Escitalopram—Pruritus—Enalapril—coronary artery disease	2.77e-05	0.000103	CcSEcCtD
Escitalopram—Diarrhoea—Pravastatin—coronary artery disease	2.77e-05	0.000103	CcSEcCtD
Escitalopram—Anxiety—Lisinopril—coronary artery disease	2.76e-05	0.000103	CcSEcCtD
Escitalopram—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	2.75e-05	0.000102	CcSEcCtD
Escitalopram—Discomfort—Lisinopril—coronary artery disease	2.74e-05	0.000102	CcSEcCtD
Escitalopram—Hypotension—Ramipril—coronary artery disease	2.74e-05	0.000102	CcSEcCtD
Escitalopram—Anorexia—Timolol—coronary artery disease	2.73e-05	0.000102	CcSEcCtD
Escitalopram—Pruritus—Telmisartan—coronary artery disease	2.73e-05	0.000102	CcSEcCtD
Escitalopram—Nausea—Eplerenone—coronary artery disease	2.73e-05	0.000101	CcSEcCtD
Escitalopram—Dizziness—Niacin—coronary artery disease	2.72e-05	0.000101	CcSEcCtD
Escitalopram—Urticaria—Losartan—coronary artery disease	2.71e-05	0.000101	CcSEcCtD
Escitalopram—Dry mouth—Lisinopril—coronary artery disease	2.71e-05	0.000101	CcSEcCtD
Escitalopram—Abdominal pain—Losartan—coronary artery disease	2.7e-05	0.0001	CcSEcCtD
Escitalopram—Body temperature increased—Losartan—coronary artery disease	2.7e-05	0.0001	CcSEcCtD
Escitalopram—Asthenia—Captopril—coronary artery disease	2.69e-05	0.0001	CcSEcCtD
Escitalopram—Diarrhoea—Trandolapril—coronary artery disease	2.69e-05	9.99e-05	CcSEcCtD
Escitalopram—Vomiting—Valsartan—coronary artery disease	2.69e-05	9.99e-05	CcSEcCtD
Escitalopram—Confusional state—Lisinopril—coronary artery disease	2.68e-05	9.96e-05	CcSEcCtD
Escitalopram—Diarrhoea—Enalapril—coronary artery disease	2.68e-05	9.95e-05	CcSEcCtD
Escitalopram—Hypotension—Timolol—coronary artery disease	2.68e-05	9.95e-05	CcSEcCtD
Escitalopram—Dizziness—Pravastatin—coronary artery disease	2.67e-05	9.95e-05	CcSEcCtD
Escitalopram—Vomiting—Olmesartan—coronary artery disease	2.67e-05	9.94e-05	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Ramipril—coronary artery disease	2.67e-05	9.93e-05	CcSEcCtD
Escitalopram—Rash—Valsartan—coronary artery disease	2.66e-05	9.91e-05	CcSEcCtD
Escitalopram—Dermatitis—Valsartan—coronary artery disease	2.66e-05	9.9e-05	CcSEcCtD
Escitalopram—Nausea—Simvastatin—coronary artery disease	2.66e-05	9.88e-05	CcSEcCtD
Escitalopram—Oedema—Lisinopril—coronary artery disease	2.66e-05	9.88e-05	CcSEcCtD
Escitalopram—Anaphylactic shock—Lisinopril—coronary artery disease	2.66e-05	9.88e-05	CcSEcCtD
Escitalopram—Pruritus—Captopril—coronary artery disease	2.65e-05	9.87e-05	CcSEcCtD
Escitalopram—Rash—Olmesartan—coronary artery disease	2.65e-05	9.86e-05	CcSEcCtD
Escitalopram—Insomnia—Ramipril—coronary artery disease	2.65e-05	9.85e-05	CcSEcCtD
Escitalopram—Dermatitis—Olmesartan—coronary artery disease	2.65e-05	9.85e-05	CcSEcCtD
Escitalopram—Headache—Valsartan—coronary artery disease	2.65e-05	9.84e-05	CcSEcCtD
Escitalopram—Diarrhoea—Telmisartan—coronary artery disease	2.64e-05	9.82e-05	CcSEcCtD
Escitalopram—Infection—Lisinopril—coronary artery disease	2.64e-05	9.82e-05	CcSEcCtD
Escitalopram—Headache—Olmesartan—coronary artery disease	2.63e-05	9.8e-05	CcSEcCtD
Escitalopram—Paraesthesia—Ramipril—coronary artery disease	2.63e-05	9.78e-05	CcSEcCtD
Escitalopram—Shock—Lisinopril—coronary artery disease	2.61e-05	9.72e-05	CcSEcCtD
Escitalopram—Asthenia—Perindopril—coronary artery disease	2.61e-05	9.72e-05	CcSEcCtD
Escitalopram—Dyspnoea—Ramipril—coronary artery disease	2.61e-05	9.71e-05	CcSEcCtD
Escitalopram—Vomiting—Niacin—coronary artery disease	2.61e-05	9.71e-05	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Timolol—coronary artery disease	2.61e-05	9.7e-05	CcSEcCtD
Escitalopram—Hypersensitivity—Furosemide—coronary artery disease	2.61e-05	9.7e-05	CcSEcCtD
Escitalopram—Somnolence—Ramipril—coronary artery disease	2.6e-05	9.69e-05	CcSEcCtD
Escitalopram—Thrombocytopenia—Lisinopril—coronary artery disease	2.6e-05	9.67e-05	CcSEcCtD
Escitalopram—Dizziness—Trandolapril—coronary artery disease	2.6e-05	9.66e-05	CcSEcCtD
Escitalopram—Tachycardia—Lisinopril—coronary artery disease	2.59e-05	9.64e-05	CcSEcCtD
Escitalopram—Insomnia—Timolol—coronary artery disease	2.59e-05	9.63e-05	CcSEcCtD
Escitalopram—Rash—Niacin—coronary artery disease	2.59e-05	9.63e-05	CcSEcCtD
Escitalopram—Dermatitis—Niacin—coronary artery disease	2.59e-05	9.62e-05	CcSEcCtD
Escitalopram—Dizziness—Enalapril—coronary artery disease	2.59e-05	9.62e-05	CcSEcCtD
Escitalopram—Skin disorder—Lisinopril—coronary artery disease	2.58e-05	9.6e-05	CcSEcCtD
Escitalopram—Dyspepsia—Ramipril—coronary artery disease	2.58e-05	9.59e-05	CcSEcCtD
Escitalopram—Pruritus—Perindopril—coronary artery disease	2.58e-05	9.58e-05	CcSEcCtD
Escitalopram—Headache—Niacin—coronary artery disease	2.57e-05	9.57e-05	CcSEcCtD
Escitalopram—Paraesthesia—Timolol—coronary artery disease	2.57e-05	9.56e-05	CcSEcCtD
Escitalopram—Vomiting—Pravastatin—coronary artery disease	2.57e-05	9.56e-05	CcSEcCtD
Escitalopram—Hyperhidrosis—Lisinopril—coronary artery disease	2.57e-05	9.55e-05	CcSEcCtD
Escitalopram—Diarrhoea—Captopril—coronary artery disease	2.57e-05	9.55e-05	CcSEcCtD
Escitalopram—Dyspnoea—Timolol—coronary artery disease	2.55e-05	9.5e-05	CcSEcCtD
Escitalopram—Dizziness—Telmisartan—coronary artery disease	2.55e-05	9.49e-05	CcSEcCtD
Escitalopram—Rash—Pravastatin—coronary artery disease	2.55e-05	9.48e-05	CcSEcCtD
Escitalopram—Dermatitis—Pravastatin—coronary artery disease	2.55e-05	9.47e-05	CcSEcCtD
Escitalopram—Decreased appetite—Ramipril—coronary artery disease	2.55e-05	9.47e-05	CcSEcCtD
Escitalopram—Somnolence—Timolol—coronary artery disease	2.55e-05	9.47e-05	CcSEcCtD
Escitalopram—Asthenia—Furosemide—coronary artery disease	2.54e-05	9.45e-05	CcSEcCtD
Escitalopram—Headache—Pravastatin—coronary artery disease	2.53e-05	9.42e-05	CcSEcCtD
Escitalopram—Anorexia—Lisinopril—coronary artery disease	2.53e-05	9.42e-05	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Ramipril—coronary artery disease	2.53e-05	9.41e-05	CcSEcCtD
Escitalopram—Fatigue—Ramipril—coronary artery disease	2.53e-05	9.39e-05	CcSEcCtD
Escitalopram—Dyspepsia—Timolol—coronary artery disease	2.52e-05	9.38e-05	CcSEcCtD
Escitalopram—Hypersensitivity—Losartan—coronary artery disease	2.52e-05	9.36e-05	CcSEcCtD
Escitalopram—Nausea—Valsartan—coronary artery disease	2.51e-05	9.33e-05	CcSEcCtD
Escitalopram—Pruritus—Furosemide—coronary artery disease	2.5e-05	9.32e-05	CcSEcCtD
Escitalopram—Constipation—Ramipril—coronary artery disease	2.5e-05	9.32e-05	CcSEcCtD
Escitalopram—Nausea—Olmesartan—coronary artery disease	2.5e-05	9.29e-05	CcSEcCtD
Escitalopram—Vomiting—Trandolapril—coronary artery disease	2.5e-05	9.29e-05	CcSEcCtD
Escitalopram—Diarrhoea—Perindopril—coronary artery disease	2.49e-05	9.27e-05	CcSEcCtD
Escitalopram—Decreased appetite—Timolol—coronary artery disease	2.49e-05	9.26e-05	CcSEcCtD
Escitalopram—Vomiting—Enalapril—coronary artery disease	2.49e-05	9.25e-05	CcSEcCtD
Escitalopram—Hypotension—Lisinopril—coronary artery disease	2.48e-05	9.23e-05	CcSEcCtD
Escitalopram—Dizziness—Captopril—coronary artery disease	2.48e-05	9.23e-05	CcSEcCtD
Escitalopram—Rash—Trandolapril—coronary artery disease	2.48e-05	9.21e-05	CcSEcCtD
Escitalopram—Dermatitis—Trandolapril—coronary artery disease	2.47e-05	9.2e-05	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Timolol—coronary artery disease	2.47e-05	9.2e-05	CcSEcCtD
Escitalopram—Fatigue—Timolol—coronary artery disease	2.47e-05	9.18e-05	CcSEcCtD
Escitalopram—Rash—Enalapril—coronary artery disease	2.47e-05	9.17e-05	CcSEcCtD
Escitalopram—Dermatitis—Enalapril—coronary artery disease	2.46e-05	9.16e-05	CcSEcCtD
Escitalopram—Headache—Trandolapril—coronary artery disease	2.46e-05	9.15e-05	CcSEcCtD
Escitalopram—Vomiting—Telmisartan—coronary artery disease	2.45e-05	9.12e-05	CcSEcCtD
Escitalopram—Asthenia—Losartan—coronary artery disease	2.45e-05	9.12e-05	CcSEcCtD
Escitalopram—Headache—Enalapril—coronary artery disease	2.45e-05	9.11e-05	CcSEcCtD
Escitalopram—Pain—Timolol—coronary artery disease	2.45e-05	9.11e-05	CcSEcCtD
Escitalopram—Nausea—Niacin—coronary artery disease	2.44e-05	9.07e-05	CcSEcCtD
Escitalopram—Rash—Telmisartan—coronary artery disease	2.43e-05	9.05e-05	CcSEcCtD
Escitalopram—Dermatitis—Telmisartan—coronary artery disease	2.43e-05	9.04e-05	CcSEcCtD
Escitalopram—Diarrhoea—Furosemide—coronary artery disease	2.42e-05	9.01e-05	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Lisinopril—coronary artery disease	2.42e-05	9e-05	CcSEcCtD
Escitalopram—Pruritus—Losartan—coronary artery disease	2.42e-05	8.99e-05	CcSEcCtD
Escitalopram—Headache—Telmisartan—coronary artery disease	2.42e-05	8.99e-05	CcSEcCtD
Escitalopram—Feeling abnormal—Ramipril—coronary artery disease	2.41e-05	8.98e-05	CcSEcCtD
Escitalopram—Dizziness—Perindopril—coronary artery disease	2.41e-05	8.96e-05	CcSEcCtD
Escitalopram—Insomnia—Lisinopril—coronary artery disease	2.4e-05	8.94e-05	CcSEcCtD
Escitalopram—Nausea—Pravastatin—coronary artery disease	2.4e-05	8.93e-05	CcSEcCtD
Escitalopram—Gastrointestinal pain—Ramipril—coronary artery disease	2.4e-05	8.91e-05	CcSEcCtD
Escitalopram—Paraesthesia—Lisinopril—coronary artery disease	2.39e-05	8.87e-05	CcSEcCtD
Escitalopram—Vomiting—Captopril—coronary artery disease	2.38e-05	8.87e-05	CcSEcCtD
Escitalopram—Dyspnoea—Lisinopril—coronary artery disease	2.37e-05	8.81e-05	CcSEcCtD
Escitalopram—Rash—Captopril—coronary artery disease	2.36e-05	8.8e-05	CcSEcCtD
Escitalopram—Dermatitis—Captopril—coronary artery disease	2.36e-05	8.79e-05	CcSEcCtD
Escitalopram—Somnolence—Lisinopril—coronary artery disease	2.36e-05	8.78e-05	CcSEcCtD
Escitalopram—Feeling abnormal—Timolol—coronary artery disease	2.36e-05	8.78e-05	CcSEcCtD
Escitalopram—Headache—Captopril—coronary artery disease	2.35e-05	8.74e-05	CcSEcCtD
Escitalopram—Gastrointestinal pain—Timolol—coronary artery disease	2.34e-05	8.71e-05	CcSEcCtD
Escitalopram—Dizziness—Furosemide—coronary artery disease	2.34e-05	8.71e-05	CcSEcCtD
Escitalopram—Dyspepsia—Lisinopril—coronary artery disease	2.34e-05	8.7e-05	CcSEcCtD
Escitalopram—Diarrhoea—Losartan—coronary artery disease	2.34e-05	8.69e-05	CcSEcCtD
Escitalopram—Nausea—Trandolapril—coronary artery disease	2.33e-05	8.68e-05	CcSEcCtD
Escitalopram—Urticaria—Ramipril—coronary artery disease	2.33e-05	8.66e-05	CcSEcCtD
Escitalopram—Nausea—Enalapril—coronary artery disease	2.32e-05	8.64e-05	CcSEcCtD
Escitalopram—Vomiting—Perindopril—coronary artery disease	2.32e-05	8.61e-05	CcSEcCtD
Escitalopram—Body temperature increased—Ramipril—coronary artery disease	2.32e-05	8.61e-05	CcSEcCtD
Escitalopram—Abdominal pain—Ramipril—coronary artery disease	2.32e-05	8.61e-05	CcSEcCtD
Escitalopram—Decreased appetite—Lisinopril—coronary artery disease	2.31e-05	8.59e-05	CcSEcCtD
Escitalopram—Rash—Perindopril—coronary artery disease	2.3e-05	8.54e-05	CcSEcCtD
Escitalopram—Dermatitis—Perindopril—coronary artery disease	2.29e-05	8.53e-05	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Lisinopril—coronary artery disease	2.29e-05	8.53e-05	CcSEcCtD
Escitalopram—Nausea—Telmisartan—coronary artery disease	2.29e-05	8.52e-05	CcSEcCtD
Escitalopram—Fatigue—Lisinopril—coronary artery disease	2.29e-05	8.52e-05	CcSEcCtD
Escitalopram—Headache—Perindopril—coronary artery disease	2.28e-05	8.49e-05	CcSEcCtD
Escitalopram—Urticaria—Timolol—coronary artery disease	2.27e-05	8.46e-05	CcSEcCtD
Escitalopram—Pain—Lisinopril—coronary artery disease	2.27e-05	8.45e-05	CcSEcCtD
Escitalopram—Constipation—Lisinopril—coronary artery disease	2.27e-05	8.45e-05	CcSEcCtD
Escitalopram—Abdominal pain—Timolol—coronary artery disease	2.26e-05	8.42e-05	CcSEcCtD
Escitalopram—Body temperature increased—Timolol—coronary artery disease	2.26e-05	8.42e-05	CcSEcCtD
Escitalopram—Dizziness—Losartan—coronary artery disease	2.26e-05	8.4e-05	CcSEcCtD
Escitalopram—Vomiting—Furosemide—coronary artery disease	2.25e-05	8.37e-05	CcSEcCtD
Escitalopram—Rash—Furosemide—coronary artery disease	2.23e-05	8.3e-05	CcSEcCtD
Escitalopram—Dermatitis—Furosemide—coronary artery disease	2.23e-05	8.3e-05	CcSEcCtD
Escitalopram—Nausea—Captopril—coronary artery disease	2.23e-05	8.29e-05	CcSEcCtD
Escitalopram—Headache—Furosemide—coronary artery disease	2.22e-05	8.25e-05	CcSEcCtD
Escitalopram—Feeling abnormal—Lisinopril—coronary artery disease	2.19e-05	8.14e-05	CcSEcCtD
Escitalopram—Gastrointestinal pain—Lisinopril—coronary artery disease	2.17e-05	8.08e-05	CcSEcCtD
Escitalopram—Vomiting—Losartan—coronary artery disease	2.17e-05	8.08e-05	CcSEcCtD
Escitalopram—Nausea—Perindopril—coronary artery disease	2.16e-05	8.05e-05	CcSEcCtD
Escitalopram—Hypersensitivity—Ramipril—coronary artery disease	2.16e-05	8.03e-05	CcSEcCtD
Escitalopram—Rash—Losartan—coronary artery disease	2.15e-05	8.01e-05	CcSEcCtD
Escitalopram—Dermatitis—Losartan—coronary artery disease	2.15e-05	8e-05	CcSEcCtD
Escitalopram—Headache—Losartan—coronary artery disease	2.14e-05	7.96e-05	CcSEcCtD
Escitalopram—Urticaria—Lisinopril—coronary artery disease	2.11e-05	7.85e-05	CcSEcCtD
Escitalopram—Hypersensitivity—Timolol—coronary artery disease	2.11e-05	7.85e-05	CcSEcCtD
Escitalopram—Nausea—Furosemide—coronary artery disease	2.1e-05	7.82e-05	CcSEcCtD
Escitalopram—Asthenia—Ramipril—coronary artery disease	2.1e-05	7.82e-05	CcSEcCtD
Escitalopram—Abdominal pain—Lisinopril—coronary artery disease	2.1e-05	7.81e-05	CcSEcCtD
Escitalopram—Body temperature increased—Lisinopril—coronary artery disease	2.1e-05	7.81e-05	CcSEcCtD
Escitalopram—Pruritus—Ramipril—coronary artery disease	2.07e-05	7.71e-05	CcSEcCtD
Escitalopram—Asthenia—Timolol—coronary artery disease	2.05e-05	7.64e-05	CcSEcCtD
Escitalopram—Nausea—Losartan—coronary artery disease	2.03e-05	7.55e-05	CcSEcCtD
Escitalopram—Pruritus—Timolol—coronary artery disease	2.03e-05	7.54e-05	CcSEcCtD
Escitalopram—Diarrhoea—Ramipril—coronary artery disease	2e-05	7.45e-05	CcSEcCtD
Escitalopram—Diarrhoea—Timolol—coronary artery disease	1.96e-05	7.29e-05	CcSEcCtD
Escitalopram—Hypersensitivity—Lisinopril—coronary artery disease	1.96e-05	7.28e-05	CcSEcCtD
Escitalopram—Dizziness—Ramipril—coronary artery disease	1.94e-05	7.2e-05	CcSEcCtD
Escitalopram—Asthenia—Lisinopril—coronary artery disease	1.91e-05	7.09e-05	CcSEcCtD
Escitalopram—Dizziness—Timolol—coronary artery disease	1.89e-05	7.04e-05	CcSEcCtD
Escitalopram—Pruritus—Lisinopril—coronary artery disease	1.88e-05	6.99e-05	CcSEcCtD
Escitalopram—Vomiting—Ramipril—coronary artery disease	1.86e-05	6.93e-05	CcSEcCtD
Escitalopram—Rash—Ramipril—coronary artery disease	1.85e-05	6.87e-05	CcSEcCtD
Escitalopram—Dermatitis—Ramipril—coronary artery disease	1.85e-05	6.86e-05	CcSEcCtD
Escitalopram—Headache—Ramipril—coronary artery disease	1.83e-05	6.83e-05	CcSEcCtD
Escitalopram—Vomiting—Timolol—coronary artery disease	1.82e-05	6.77e-05	CcSEcCtD
Escitalopram—Diarrhoea—Lisinopril—coronary artery disease	1.82e-05	6.76e-05	CcSEcCtD
Escitalopram—Rash—Timolol—coronary artery disease	1.81e-05	6.72e-05	CcSEcCtD
Escitalopram—Dermatitis—Timolol—coronary artery disease	1.8e-05	6.71e-05	CcSEcCtD
Escitalopram—Headache—Timolol—coronary artery disease	1.79e-05	6.67e-05	CcSEcCtD
Escitalopram—Dizziness—Lisinopril—coronary artery disease	1.76e-05	6.53e-05	CcSEcCtD
Escitalopram—Nausea—Ramipril—coronary artery disease	1.74e-05	6.47e-05	CcSEcCtD
Escitalopram—Nausea—Timolol—coronary artery disease	1.7e-05	6.33e-05	CcSEcCtD
Escitalopram—Vomiting—Lisinopril—coronary artery disease	1.69e-05	6.28e-05	CcSEcCtD
Escitalopram—Rash—Lisinopril—coronary artery disease	1.67e-05	6.23e-05	CcSEcCtD
Escitalopram—Dermatitis—Lisinopril—coronary artery disease	1.67e-05	6.22e-05	CcSEcCtD
Escitalopram—Headache—Lisinopril—coronary artery disease	1.66e-05	6.19e-05	CcSEcCtD
Escitalopram—Nausea—Lisinopril—coronary artery disease	1.58e-05	5.87e-05	CcSEcCtD
Escitalopram—CYP3A4—Metabolism—APOA5—coronary artery disease	4.3e-06	4.42e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—PRKCD—coronary artery disease	4.29e-06	4.42e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—F2—coronary artery disease	4.27e-06	4.39e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—FN1—coronary artery disease	4.27e-06	4.39e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—IL6ST—coronary artery disease	4.25e-06	4.37e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—ABCA1—coronary artery disease	4.23e-06	4.36e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—PRKCD—coronary artery disease	4.23e-06	4.35e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—HTR2A—coronary artery disease	4.22e-06	4.34e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—NFKBIA—coronary artery disease	4.22e-06	4.34e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—P4HB—coronary artery disease	4.21e-06	4.34e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—C3—coronary artery disease	4.21e-06	4.34e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—HTR2A—coronary artery disease	4.2e-06	4.33e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—C3—coronary artery disease	4.2e-06	4.32e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—HTR2A—coronary artery disease	4.14e-06	4.26e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	4.14e-06	4.26e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—C3—coronary artery disease	4.13e-06	4.25e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—GGT1—coronary artery disease	4.1e-06	4.22e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—GOT1—coronary artery disease	4.1e-06	4.22e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—KIT—coronary artery disease	4.08e-06	4.2e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—HIF1A—coronary artery disease	4.02e-06	4.13e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—GSTP1—coronary artery disease	4e-06	4.12e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—HIF1A—coronary artery disease	4e-06	4.12e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—AGT—coronary artery disease	4e-06	4.12e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—AGT—coronary artery disease	3.99e-06	4.11e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—PPARGC1A—coronary artery disease	3.97e-06	4.09e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—HMOX1—coronary artery disease	3.95e-06	4.07e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—HIF1A—coronary artery disease	3.94e-06	4.06e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—AGT—coronary artery disease	3.93e-06	4.04e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—LEP—coronary artery disease	3.92e-06	4.04e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—APOE—coronary artery disease	3.92e-06	4.04e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—GSK3B—coronary artery disease	3.92e-06	4.03e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—LEP—coronary artery disease	3.91e-06	4.02e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—APOE—coronary artery disease	3.91e-06	4.02e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—VCAN—coronary artery disease	3.9e-06	4.01e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—CAT—coronary artery disease	3.9e-06	4.01e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—POMC—coronary artery disease	3.89e-06	4e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CREB1—coronary artery disease	3.89e-06	4e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—APOA1—coronary artery disease	3.87e-06	3.99e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—ALDOA—coronary artery disease	3.87e-06	3.98e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—APOA1—coronary artery disease	3.86e-06	3.98e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—APOE—coronary artery disease	3.85e-06	3.96e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—LEP—coronary artery disease	3.85e-06	3.96e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—KDR—coronary artery disease	3.84e-06	3.95e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—KDR—coronary artery disease	3.83e-06	3.94e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—MAPK14—coronary artery disease	3.81e-06	3.93e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—MAPK14—coronary artery disease	3.8e-06	3.92e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—APOA1—coronary artery disease	3.8e-06	3.91e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CCL2—coronary artery disease	3.8e-06	3.91e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—IL6R—coronary artery disease	3.79e-06	3.9e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—APOB—coronary artery disease	3.78e-06	3.9e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—KDR—coronary artery disease	3.77e-06	3.88e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—DCN—coronary artery disease	3.75e-06	3.87e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—MAPK14—coronary artery disease	3.74e-06	3.85e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—ESR1—coronary artery disease	3.74e-06	3.85e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—IGF1—coronary artery disease	3.74e-06	3.85e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—ESR1—coronary artery disease	3.73e-06	3.84e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—MAPK1—coronary artery disease	3.72e-06	3.83e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—FN1—coronary artery disease	3.7e-06	3.81e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—F2—coronary artery disease	3.7e-06	3.81e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—F2—coronary artery disease	3.68e-06	3.79e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—FN1—coronary artery disease	3.68e-06	3.79e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—GSTP1—coronary artery disease	3.68e-06	3.79e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—IL6ST—coronary artery disease	3.68e-06	3.79e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—GSTM1—coronary artery disease	3.68e-06	3.79e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—ESR1—coronary artery disease	3.67e-06	3.78e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—IL6ST—coronary artery disease	3.67e-06	3.78e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—ALDH2—coronary artery disease	3.65e-06	3.76e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—NFKBIA—coronary artery disease	3.65e-06	3.76e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—PPARGC1A—coronary artery disease	3.65e-06	3.76e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—NFKBIA—coronary artery disease	3.64e-06	3.75e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—HMOX1—coronary artery disease	3.63e-06	3.74e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—FN1—coronary artery disease	3.63e-06	3.73e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—F2—coronary artery disease	3.63e-06	3.73e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—IL6ST—coronary artery disease	3.61e-06	3.72e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—LPL—coronary artery disease	3.61e-06	3.72e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—CAT—coronary artery disease	3.58e-06	3.69e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—NFKBIA—coronary artery disease	3.58e-06	3.69e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—HBA1—coronary artery disease	3.56e-06	3.67e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CYP2C19—coronary artery disease	3.56e-06	3.67e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	3.56e-06	3.67e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—LIPC—coronary artery disease	3.56e-06	3.67e-05	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—PIK3CA—coronary artery disease	3.55e-06	3.66e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—SERPINE1—coronary artery disease	3.55e-06	3.65e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—APOC3—coronary artery disease	3.54e-06	3.64e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—KIT—coronary artery disease	3.54e-06	3.64e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—KIT—coronary artery disease	3.53e-06	3.63e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—GPX1—coronary artery disease	3.52e-06	3.63e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—LDLR—coronary artery disease	3.52e-06	3.62e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—APOB—coronary artery disease	3.48e-06	3.58e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—GSTT1—coronary artery disease	3.47e-06	3.58e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—SLC9A1—coronary artery disease	3.47e-06	3.58e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—KIT—coronary artery disease	3.47e-06	3.57e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—FGF2—coronary artery disease	3.44e-06	3.54e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CETP—coronary artery disease	3.43e-06	3.54e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—GCLC—coronary artery disease	3.43e-06	3.54e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—CD36—coronary artery disease	3.43e-06	3.53e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—SDC1—coronary artery disease	3.4e-06	3.5e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—GSK3B—coronary artery disease	3.39e-06	3.5e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—PPP2CA—coronary artery disease	3.39e-06	3.49e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—NOS3—coronary artery disease	3.39e-06	3.49e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—GSTM1—coronary artery disease	3.38e-06	3.49e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—GSK3B—coronary artery disease	3.38e-06	3.48e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—POMC—coronary artery disease	3.37e-06	3.47e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CREB1—coronary artery disease	3.37e-06	3.47e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—POMC—coronary artery disease	3.36e-06	3.46e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CREB1—coronary artery disease	3.36e-06	3.46e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—GSK3B—coronary artery disease	3.33e-06	3.43e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—LPL—coronary artery disease	3.32e-06	3.42e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—POMC—coronary artery disease	3.3e-06	3.4e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CREB1—coronary artery disease	3.3e-06	3.4e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CCL2—coronary artery disease	3.29e-06	3.39e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—JAK2—coronary artery disease	3.29e-06	3.39e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—IL6R—coronary artery disease	3.28e-06	3.38e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CCL2—coronary artery disease	3.28e-06	3.38e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—IL6R—coronary artery disease	3.27e-06	3.37e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—MTHFR—coronary artery disease	3.25e-06	3.35e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—GPX1—coronary artery disease	3.24e-06	3.34e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—IGF1—coronary artery disease	3.24e-06	3.33e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CCL2—coronary artery disease	3.23e-06	3.33e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—IGF1—coronary artery disease	3.23e-06	3.32e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—PIK3CA—coronary artery disease	3.23e-06	3.32e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—MAPK1—coronary artery disease	3.22e-06	3.32e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—IL6R—coronary artery disease	3.22e-06	3.32e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—MAPK1—coronary artery disease	3.21e-06	3.31e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PSMA6—coronary artery disease	3.21e-06	3.3e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PSMB5—coronary artery disease	3.21e-06	3.3e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—IGF1—coronary artery disease	3.18e-06	3.27e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—MAPK1—coronary artery disease	3.16e-06	3.26e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—CD36—coronary artery disease	3.16e-06	3.25e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CTGF—coronary artery disease	3.13e-06	3.23e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—PPP2CA—coronary artery disease	3.12e-06	3.21e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—HMGCR—coronary artery disease	3.11e-06	3.2e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—GOT2—coronary artery disease	3.11e-06	3.2e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—AGT—coronary artery disease	3.09e-06	3.18e-05	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—PIK3CA—coronary artery disease	3.08e-06	3.17e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—SERPINE1—coronary artery disease	3.08e-06	3.17e-05	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—PIK3CA—coronary artery disease	3.07e-06	3.16e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—SERPINE1—coronary artery disease	3.07e-06	3.16e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—APOE—coronary artery disease	3.03e-06	3.12e-05	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—PIK3CA—coronary artery disease	3.02e-06	3.11e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—SERPINE1—coronary artery disease	3.02e-06	3.11e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CXCL8—coronary artery disease	3.01e-06	3.1e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—APOA1—coronary artery disease	2.99e-06	3.08e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—MTHFR—coronary artery disease	2.99e-06	3.08e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—FGF2—coronary artery disease	2.98e-06	3.07e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—FGF2—coronary artery disease	2.97e-06	3.06e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—NOS3—coronary artery disease	2.94e-06	3.02e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—NOS3—coronary artery disease	2.93e-06	3.01e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—FGF2—coronary artery disease	2.92e-06	3.01e-05	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—AKT1—coronary artery disease	2.9e-06	2.99e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—NOS3—coronary artery disease	2.88e-06	2.97e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CASP3—coronary artery disease	2.88e-06	2.96e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	2.87e-06	2.95e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—IL6—coronary artery disease	2.86e-06	2.94e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PLCB1—coronary artery disease	2.86e-06	2.94e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—JAK2—coronary artery disease	2.85e-06	2.94e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—JAK2—coronary artery disease	2.84e-06	2.93e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—AGT—coronary artery disease	2.84e-06	2.93e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—JAK2—coronary artery disease	2.8e-06	2.88e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CCND1—coronary artery disease	2.8e-06	2.88e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—PIK3CA—coronary artery disease	2.8e-06	2.88e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—PIK3CA—coronary artery disease	2.79e-06	2.87e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—APOE—coronary artery disease	2.79e-06	2.87e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—ABCA1—coronary artery disease	2.77e-06	2.85e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—APOA1—coronary artery disease	2.75e-06	2.83e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—PIK3CA—coronary artery disease	2.74e-06	2.83e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—MMP9—coronary artery disease	2.72e-06	2.8e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—GGT1—coronary artery disease	2.68e-06	2.76e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—GOT1—coronary artery disease	2.68e-06	2.76e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—PPARG—coronary artery disease	2.64e-06	2.72e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—AKT1—coronary artery disease	2.64e-06	2.72e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CXCL8—coronary artery disease	2.6e-06	2.68e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—POMC—coronary artery disease	2.6e-06	2.68e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CXCL8—coronary artery disease	2.6e-06	2.67e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CXCL8—coronary artery disease	2.56e-06	2.63e-05	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—AKT1—coronary artery disease	2.52e-06	2.59e-05	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—AKT1—coronary artery disease	2.51e-06	2.58e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CASP3—coronary artery disease	2.49e-06	2.57e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CASP3—coronary artery disease	2.49e-06	2.56e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—IL6—coronary artery disease	2.48e-06	2.55e-05	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—AKT1—coronary artery disease	2.47e-06	2.54e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—IL6—coronary artery disease	2.47e-06	2.54e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CASP3—coronary artery disease	2.45e-06	2.52e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—VEGFA—coronary artery disease	2.44e-06	2.51e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—IL6—coronary artery disease	2.43e-06	2.5e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CCND1—coronary artery disease	2.43e-06	2.5e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—PPARG—coronary artery disease	2.43e-06	2.5e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CCND1—coronary artery disease	2.42e-06	2.49e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—GSTP1—coronary artery disease	2.41e-06	2.48e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—POMC—coronary artery disease	2.39e-06	2.46e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	2.39e-06	2.46e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CCND1—coronary artery disease	2.38e-06	2.45e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—HMOX1—coronary artery disease	2.38e-06	2.45e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—ALB—coronary artery disease	2.37e-06	2.44e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—MMP9—coronary artery disease	2.36e-06	2.43e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—MMP9—coronary artery disease	2.35e-06	2.42e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CAT—coronary artery disease	2.34e-06	2.41e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—MMP9—coronary artery disease	2.31e-06	2.38e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—AKT1—coronary artery disease	2.29e-06	2.35e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—AKT1—coronary artery disease	2.28e-06	2.35e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—APOB—coronary artery disease	2.27e-06	2.34e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—NOS3—coronary artery disease	2.27e-06	2.34e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—AKT1—coronary artery disease	2.24e-06	2.31e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—TGFB1—coronary artery disease	2.24e-06	2.31e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—GSTM1—coronary artery disease	2.21e-06	2.28e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—MAPK1—coronary artery disease	2.2e-06	2.26e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—ALB—coronary artery disease	2.18e-06	2.25e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—LPL—coronary artery disease	2.17e-06	2.24e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—GPX1—coronary artery disease	2.12e-06	2.18e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—VEGFA—coronary artery disease	2.12e-06	2.18e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—VEGFA—coronary artery disease	2.11e-06	2.17e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—NOS3—coronary artery disease	2.09e-06	2.15e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—VEGFA—coronary artery disease	2.08e-06	2.14e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—PTGS2—coronary artery disease	2.07e-06	2.14e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CD36—coronary artery disease	2.06e-06	2.13e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PPP2CA—coronary artery disease	2.04e-06	2.1e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—MTHFR—coronary artery disease	1.96e-06	2.01e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—TGFB1—coronary artery disease	1.94e-06	2e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—TGFB1—coronary artery disease	1.94e-06	1.99e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—PTGS2—coronary artery disease	1.91e-06	1.96e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—PIK3CA—coronary artery disease	1.91e-06	1.96e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—TGFB1—coronary artery disease	1.91e-06	1.96e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—MAPK1—coronary artery disease	1.9e-06	1.96e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—MAPK1—coronary artery disease	1.9e-06	1.95e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—MAPK1—coronary artery disease	1.87e-06	1.92e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—AGT—coronary artery disease	1.86e-06	1.91e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—APOE—coronary artery disease	1.82e-06	1.87e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—APOA1—coronary artery disease	1.8e-06	1.85e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—IL6—coronary artery disease	1.69e-06	1.74e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—PIK3CA—coronary artery disease	1.65e-06	1.7e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—PIK3CA—coronary artery disease	1.65e-06	1.7e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—PIK3CA—coronary artery disease	1.62e-06	1.67e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PPARG—coronary artery disease	1.59e-06	1.63e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—POMC—coronary artery disease	1.56e-06	1.61e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—AKT1—coronary artery disease	1.56e-06	1.6e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—IL6—coronary artery disease	1.46e-06	1.51e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—IL6—coronary artery disease	1.46e-06	1.5e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—IL6—coronary artery disease	1.44e-06	1.48e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—ALB—coronary artery disease	1.43e-06	1.47e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—NOS3—coronary artery disease	1.36e-06	1.4e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—AKT1—coronary artery disease	1.35e-06	1.39e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—AKT1—coronary artery disease	1.35e-06	1.39e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—AKT1—coronary artery disease	1.32e-06	1.36e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—PIK3CA—coronary artery disease	1.28e-06	1.31e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PTGS2—coronary artery disease	1.25e-06	1.28e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—PIK3CA—coronary artery disease	1.17e-06	1.21e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—AKT1—coronary artery disease	1.04e-06	1.07e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—AKT1—coronary artery disease	9.59e-07	9.88e-06	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PIK3CA—coronary artery disease	7.68e-07	7.9e-06	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—AKT1—coronary artery disease	6.27e-07	6.46e-06	CbGpPWpGaD
